Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic therapy for HIV/AIDS.

Ananthalakshmi Poluri1, Marc van Maanen, Richard E Sutton

  • 1Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA. rsutton@bcm.tmc.edu

Expert Opinion on Biological Therapy
|August 29, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Split Reporter Systems in Viral Protein-Protein Interactions and Multimerization: Mechanisms and Applications.

Cells·2026
Same author

Next-Generation HIV-1 Therapeutics in Co-Endemic Settings.

Biomedicines·2026
Same author

Use of the Split Luciferase Complementation Assay to Identify Novel Small Molecules That Disrupt Essential Protein-Protein Interactions of Viruses.

Biomolecules·2025
Same author

I Died-and Was Brought Back to Life-Twice.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

The role of the 3'-UTR of the chemokine receptor CCR2 and hnRNPA0 in regulating mRNA stability and subcellular distribution in human CD4<sup>+</sup> T cells.

Frontiers in immunology·2025
Same author

Targeting CCR5: A central approach to HIV treatment and cure strategies.

Virology·2024

Gene transfer therapies offer innovative strategies for treating human immunodeficiency virus (HIV) infection, complementing highly active antiretroviral treatment (HAART). Research explores various gene targets and delivery vectors, with early clinical trials indicating safety and potential for future development.

Area of Science:

  • * Molecular biology
  • * Virology
  • * Immunology

Background:

  • * Highly active antiretroviral treatment (HAART) has significantly advanced human immunodeficiency virus (HIV) management.
  • * A substantial patient population still requires innovative therapeutic strategies beyond HAART.
  • * Gene transfer approaches represent a promising area for novel anti-HIV interventions.

Purpose of the Study:

  • * To review potential gene therapeutic targets for HIV, encompassing both viral and cellular genes.
  • * To explore diverse gene transfer methods and delivery vectors for inhibiting HIV replication.
  • * To assess the current status and future directions of HIV gene therapy research.

Main Methods:

  • * Identification of viral and cellular gene targets crucial for HIV replication.

Related Experiment Videos

  • * Examination of RNA-based strategies (e.g., siRNA, ribozymes) and other gene-based approaches (e.g., dominant negative proteins, suicide genes).
  • * Evaluation of gene delivery vectors, including retroviral and lentiviral systems.
  • * Review of findings from early-phase clinical trials.

    • Main Results:

    • * Multiple gene targets and therapeutic strategies have shown promise in vitro.
    • * Retroviral and lentiviral vectors demonstrate high gene transfer efficiency.
    • * Phase I clinical trials suggest that HIV gene therapy is generally safe.
    • * Various RNA-based and protein-based gene strategies are effective in inhibiting viral replication.

    Conclusions:

    • * Gene therapy holds significant potential as an innovative treatment for HIV.
    • * Lentiviral vectors are efficient for gene delivery in HIV gene therapy.
    • * Further clinical investigation is warranted to establish the efficacy of HIV gene therapy approaches.
    • * A coordinated national network could facilitate the clinical advancement of HIV gene therapy.